Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-5
|
Results: 5
Maternal and transplacental pharmacokinetics of cefazolin
Authors:
Mitchell, TF Pearlman, MD Chapman, RL Bhatt-Mehta, V Faix, RG
Citation:
Tf. Mitchell et al., Maternal and transplacental pharmacokinetics of cefazolin, OBSTET GYN, 98(6), 2001, pp. 1075-1079
Persistently positive cultures and outcome in invasive neonatal candidiasis
Authors:
Chapman, RL Faix, RG
Citation:
Rl. Chapman et Rg. Faix, Persistently positive cultures and outcome in invasive neonatal candidiasis, PEDIAT INF, 19(9), 2000, pp. 822-827
Antithrombotic therapy in pediatrics: Time for higher levels of evidence
Authors:
Faix, RG
Citation:
Rg. Faix, Antithrombotic therapy in pediatrics: Time for higher levels of evidence, J PEDIAT, 136(4), 2000, pp. 425-426
Lack of vancomycin-associated nephrotoxicity in newborn infants: A case-control study
Authors:
Bhatt-Mehta, V Schumacher, RE Faix, RG Leady, M Brenner, T
Citation:
V. Bhatt-mehta et al., Lack of vancomycin-associated nephrotoxicity in newborn infants: A case-control study, PEDIATRICS, 103(4), 1999, pp. E481-E484
Comments on palivizumab (Synagis)
Authors:
Moler, FW Brown, RW Faix, RG Gilsdorf, JR
Citation:
Fw. Moler et al., Comments on palivizumab (Synagis), PEDIATRICS, 103(2), 1999, pp. 495-497
Risultati:
1-5
|